Searchable abstracts of presentations at key conferences in endocrinology

ea0077ce1.2 | Use and abuse endocrinology - enhancing performance at any cost? | SFEBES2021

GH as a performance enhancing drug

Holt Richard

Anecdotal evidence suggests that athletes have been misusing growth hormone (GH) for its anabolic, lipolytic, psychological and cardiovascular effects since the early 1980s, at least a decade before endocrinologists began to treat adults with GH deficiency. There have been on-going debates about whether GH is performance-enhancing. Although many of the early studies were negative, randomized controlled...

ea0031mte7 | (1) | SFEBES2013

Hormone misuse in sport and leisure

Holt Richard

When humans are placed in a competitive setting, particularly in the sporting arena, they will attempt to gain an advantage over their opponent in order to win. When all legitimate methods have been exhausted and the athlete has reached their peak performance, there is a temptation for some to seek out pharmacological methods to improve performance yet further.The earliest records of doping in sport come from ancient times but with the advent of modern p...

ea0030s11 | Symposium 3 The Olympiad! | BSPED2012

Beyond reasonable doubt: catching the GH cheats

Holt Richard

There is widespread anecdotal evidence that GH has been misused by athletes, including adolescents, for its anabolic and lipolytic properties since the early 1980s, at least a decade before GH was used therapeutically by adult endocrinologists. Since then a number of high profile athletes have admitted using GH. Despite its widespread abuse, there is debate about whether GH is ergogenic. Until recently most scientific studies have not shown a performance enhancing effect but m...

ea0025p142 | Diabetes, metabolism and cardiovascular | SFEBES2011

Retinal screening in pregnant women with diabetes: ‘are we doing enough'

Mlawa Gideon , Holt Richard , Coleman Mathew , Rennie Christina , Smith Roger

Introduction: NICE recommends that pregnant women with pre-existing diabetes should be offered retinal assessment in the 1st and 3rd trimester by digital retinal imaging. Where retinopathy is already present, an additional assessment should be made in the 2nd trimester.Objectives: To assess the feasibility of retinal screening in pregnancy by a community based mobile retinal screening programme (MRSP).Methods: A retrospective audit...

ea0025p115 | Cytokines, growth factors, neuroendocrinology and behaviour | SFEBES2011

The effects of recombinant human IGF1/IGF binding protein-3 on lipid and glucose metabolism in recreational athletes

Guha Nishan , Erotokritou-Mulligan Ioulietta , Nevitt Simon , Francis Michael , Bassett Eryl , Sonksen Peter , Holt Richard

Introduction: Recombinant human IGF1 (rhIGF1) improves insulin sensitivity and glycaemic control when administered to people with diabetes. The effects of rhIGF1 on lipid metabolism in vivo are unclear.Objectives: To determine the effects of rhIGF1/rhIGFBP3 administration on fasting lipids, non-esterified fatty acids (NEFA) and glucose homeostasis in recreational athletes. This study was part of a randomised, double-blind, placebo-controlled trial...

ea0025p114 | Cytokines, growth factors, neuroendocrinology and behaviour | SFEBES2011

The effects of recombinant human IGF1/IGF binding protein-3 on body composition and physical fitness in recreational athletes

Guha Nishan , Erotokritou-Mulligan Ioulietta , Nevitt Simon , Francis Michael , Woodland John , Bassett Eryl , Sonksen Peter , Holt Richard

Introduction: GH is widely abused by athletes for its anabolic and lipolytic properties. As the tests for detecting GH abuse develop further, it is possible that athletes will exploit IGF1 as an alternative or additional doping agent. There is currently no evidence to suggest that IGF1 administration improves athletic performance.Objectives: To determine the effects of rhIGF1/rhIGFBP3 administration on body composition and physical fitness in recreationa...